Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study-Reference-Cited by-同舟云学术

Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study

Published:2014-07-17 Issue:8 Volume:14 Page:1817-1827
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Klintmalm G. B.¹,Feng S.²,Lake J. R.³,Vargas H. E.⁴,Wekerle T.⁵,Agnes S.⁶,Brown K. A.⁷,Nashan B.⁸,Rostaing L.⁹¹⁰,Meadows‐Shropshire S.¹¹,Agarwal M.¹²,Harler M. B.¹²,García‐Valdecasas J.‐C.¹³

Affiliation:

1. Annette C. and Harold C. Simmons Transplant InstituteBaylor University Medical CenterDallasTX

2. Division of Transplant SurgeryUniversity of California, San FranciscoSan FranciscoCA

3. Liver Transplant ProgramUniversity of MinnesotaMinneapolisMN

4. Division of HepatologyMayo Clinic ArizonaPhoenixAZ

5. Division of TransplantationMedical University of ViennaViennaAustria

6. Department of General and Transplant SurgeryCatholic University, Policlinico “A. Gemelli”RomeItaly

7. Division of GastroenterologyHenry Ford Health SystemsDetroitMI

8. Department of Hepatobiliary Surgery & Visceral TransplantationUniversity Medical Center Hamburg‐EppendorfHamburgGermany

9. Department of Nephrology and Organ TransplantationToulouse University HospitalToulouseFrance

10. INSERM U1043, IFR‐BMTCHU PurpanToulouseFrance

11. Bristol‐Myers SquibbHopewellNJ

12. Bristol‐Myers SquibbPrincetonNJ

13. Liver Transplant UnitHospital Clinic of BarcelonaBarcelonaSpain

Funder

Bristol-Myers Squibb

ClinicalTrials.gov

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.12810

Reference27 articles.

1. The Survival Benefit of Liver Transplantation

2. Survival Benefit After Liver Transplantation: A Single European Center Experience

3. Cardiovascular morbidity and mortality after orthotopic liver transplantation

4. Chronic Renal Failure after Transplantation of a Nonrenal Organ

5. RENAL REPLACEMENT THERAPY AND ORTHOTOPIC LIVER TRANSPLANTATION: THE ROLE OF CONTINUOUS VENO-VENOUS HEMODIALYSIS 1

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing immunosuppression in liver transplantation: A narrative review;Hepatobiliary & Pancreatic Diseases International;2024-10

2. Transplant Immunology in Liver Transplant, Rejection, and Tolerance;Livers;2024-09-09

3. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

4. Long-term Safety in Epstein–Barr Virus–Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry;Transplantation Direct;2024-05-17

5. How to prevent chronic kidney disease after liver transplantation?;Annals of Liver Transplantation;2024-05-16